Stock News

Tobam Has Boosted Its Teva Pharmaceutical (TEVA) Position by $6.28 Million; Livforsakringsbolaget Skandia Omsesidigt Has Lifted Its Cvs Health (CVS) Stake by $849,600

CVS Health Corporation (NYSE:CVS) Logo

Tobam increased its stake in Teva Pharmaceutical (TEVA) by 66.7% based on its latest 2017Q4 regulatory filing with the SEC. Tobam bought 348,762 shares as the company’s stock declined 11.04% with the market. The institutional investor held 871,607 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $16.52 million, up from 522,845 at the end of the previous reported quarter. Tobam who had been investing in Teva Pharmaceutical for a number of months, seems to be bullish on the $21.26 billion market cap company. The stock increased 2.86% or $0.58 during the last trading session, reaching $20.88. About 23.90 million shares traded or 109.15% up from the average. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 49.50% since May 17, 2017 and is downtrending. It has underperformed by 61.05% the S&P500.

Livforsakringsbolaget Skandia Omsesidigt increased its stake in Cvs Health Corp (CVS) by 17.86% based on its latest 2017Q4 regulatory filing with the SEC. Livforsakringsbolaget Skandia Omsesidigt bought 11,800 shares as the company’s stock declined 17.45% with the market. The institutional investor held 77,859 shares of the medical and nursing services company at the end of 2017Q4, valued at $5.65 million, up from 66,059 at the end of the previous reported quarter. Livforsakringsbolaget Skandia Omsesidigt who had been investing in Cvs Health Corp for a number of months, seems to be bullish on the $67.23B market cap company. The stock increased 0.44% or $0.29 during the last trading session, reaching $66.13. About 5.97 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since May 17, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Livforsakringsbolaget Skandia Omsesidigt, which manages about $1.05B US Long portfolio, decreased its stake in Amazon.Com Inc (NASDAQ:AMZN) by 3,090 shares to 7,636 shares, valued at $8.93M in 2017Q4, according to the filing. It also reduced its holding in Paypal Holdings Inc by 5,500 shares in the quarter, leaving it with 17,326 shares, and cut its stake in Costco Wholesale Corp (NASDAQ:COST).

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “We Are Playing The CVS Hand” on May 11, 2018, also Bizjournals.com with their article: “Moody’s likes the upward financial trend at this Lakeland pharmacy benefits manager” published on May 16, 2018, 247Wallst.com published: “Alibaba, CVS, Tesla and Other Earnings to Watch For This Week” on April 29, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Seekingalpha.com and their article: “Trade Mistake 3: CVS Boredom Trade” published on May 09, 2018 as well as Seekingalpha.com‘s news article titled: “CVS Health: A Store-Level Look At The Proposed Healthcare Giant” with publication date: April 26, 2018.

Investors sentiment decreased to 0.72 in 2017 Q4. Its down 0.16, from 0.88 in 2017Q3. It worsened, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Aqr Capital Mgmt holds 0.26% in CVS Health Corporation (NYSE:CVS) or 3.38 million shares. Baldwin Brothers Ma has invested 0.03% in CVS Health Corporation (NYSE:CVS). Twin Mgmt Inc has invested 0.4% of its portfolio in CVS Health Corporation (NYSE:CVS). Davenport And Company Ltd Liability Company holds 0.64% of its portfolio in CVS Health Corporation (NYSE:CVS) for 730,799 shares. Mengis Cap Mngmt owns 0.49% invested in CVS Health Corporation (NYSE:CVS) for 11,280 shares. Strategic holds 0.77% in CVS Health Corporation (NYSE:CVS) or 67,073 shares. Atwood And Palmer Inc owns 199,511 shares. Primecap Company Ca stated it has 0.19% in CVS Health Corporation (NYSE:CVS). Ubs Asset Management Americas has invested 0.22% of its portfolio in CVS Health Corporation (NYSE:CVS). British Columbia Investment Mgmt Corporation reported 0.22% stake. Moreover, Kornitzer Capital Mngmt Incorporated Ks has 0.05% invested in CVS Health Corporation (NYSE:CVS) for 37,385 shares. Intact Investment Mngmt has invested 0.09% in CVS Health Corporation (NYSE:CVS). Lsv Asset Management invested in 0.1% or 851,857 shares. Zwj Invest Counsel Incorporated has invested 0.07% of its portfolio in CVS Health Corporation (NYSE:CVS). Mercer Capital Advisers stated it has 1,500 shares.

Since February 16, 2018, it had 2 insider purchases, and 1 sale for $713,454 activity. DORMAN DAVID W bought $1.51 million worth of CVS Health Corporation (NYSE:CVS) on Friday, May 4. 10,000 shares were bought by BROWN C DAVID II, worth $619,900.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 77 analyst reports since July 22, 2015 according to SRatingsIntel. Jefferies maintained it with “Hold” rating and $8200 target in Friday, June 9 report. The stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by Tigress Financial on Friday, April 28. Needham upgraded CVS Health Corporation (NYSE:CVS) on Tuesday, January 30 to “Buy” rating. S&P Research maintained CVS Health Corporation (NYSE:CVS) on Monday, November 2 with “Strong Buy” rating. On Thursday, February 8 the stock rating was maintained by RBC Capital Markets with “Buy”. The rating was maintained by Leerink Swann with “Buy” on Tuesday, April 10. The rating was maintained by Needham on Monday, December 4 with “Buy”. Jefferies maintained CVS Health Corporation (NYSE:CVS) on Wednesday, October 18 with “Hold” rating. The rating was maintained by SunTrust with “Buy” on Thursday, January 4. The firm has “Hold” rating given on Wednesday, August 16 by Wolfe Research.

Tobam, which manages about $5.57B and $2.31B US Long portfolio, decreased its stake in Csx Corp (NYSE:CSX) by 217,470 shares to 330,429 shares, valued at $18.18M in 2017Q4, according to the filing. It also reduced its holding in Darden Restaurants Inc (NYSE:DRI) by 44,597 shares in the quarter, leaving it with 326,494 shares, and cut its stake in Extra Space Storage Inc (NYSE:EXR).

More notable recent Teva Pharmaceutical Industries Limited (NYSE:TEVA) news were published by: Globes.Co.Il which released: “FDA delays approving Perrigo’s generic Teva inhaler” on May 13, 2018, also Globes.Co.Il with their article: “Mon: Teva rally lifts TASE” published on May 14, 2018, Fool.com published: “Why Teva Pharmaceutical Industries, Gramercy Property Trust, and Medtronic Jumped Today” on May 07, 2018. More interesting news about Teva Pharmaceutical Industries Limited (NYSE:TEVA) were released by: Seekingalpha.com and their article: “Teva: A Better Entry Point Post-Results” published on May 06, 2018 as well as Streetinsider.com‘s news article titled: “After-Hours Stock Movers 05/15: (BOOT) (TEVA) (ZSAN) Higher; (VSTM) (SRAX) (ABR) Lower (more…)” with publication date: May 15, 2018.

Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 153 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Hold” rating by Piper Jaffray on Friday, October 6. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) has “Hold” rating given on Friday, February 9 by RBC Capital Markets. The firm has “Outperform” rating given on Monday, February 12 by Credit Suisse. The firm has “Buy” rating given on Tuesday, June 27 by Oppenheimer. As per Monday, November 7, the company rating was downgraded by Bank of America. Credit Suisse upgraded the shares of TEVA in report on Friday, December 15 to “Neutral” rating. As per Wednesday, January 4, the company rating was maintained by Maxim Group. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) has “Hold” rating given on Tuesday, December 12 by Guggenheim. Deutsche Bank maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Friday, February 9 with “Hold” rating. Deutsche Bank downgraded the shares of TEVA in report on Friday, November 3 to “Hold” rating.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *